Consensus LeMaitre Vascular, Inc.

Stocks

LMAT

US5255582018

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 23:00:00 02/10/2026 +03			5-day change	1st Jan Change
78.96 ^USD	-1.53%		-3.14%	-2.64%

08-06	Barrington Upgrades LeMaitre Vascular to Outperform From Market Perform, Price Target is $95	MT
08-05	Barrington Downgrades LeMaitre Vascular to Market Perform From Outperform	MT

Evolution of the Average Target: LeMaitre Vascular, Inc.

Evolution of the Target Price: LeMaitre Vascular, Inc.

Changes in Analyst Recommendations: LeMaitre Vascular, Inc.

690bc12.5tSHoy-02_teTxRMMLs9jC8gKpdk0Arn3K7aMe_ahMQ.g4Hyx1vsqqMKPic0U89b72B1W_gnoXOur8vjY9rptvCgm6rJeIbolwcsQQ~85cd9a308b3245b6dffa962bd99cb136

Analysts' recommendations: LeMaitre Vascular, Inc.

08-06	Barrington Upgrades LeMaitre Vascular to Outperform From Market Perform, Price Target is $95	MT
08-05	Barrington Downgrades LeMaitre Vascular to Market Perform From Outperform	MT
05-06	Barrington Adjusts Price Target on LeMaitre Vascular to $120 From $105, Maintains Outperform Rating	MT
02-26	LeMaitre Vascular Shares Rise After Barrington Price Target Boost, Q4 Results	MT
02-26	Barrington Adjusts Price Target on LeMaitre Vascular to $105 From $95, Maintains Outperform Rating	MT
05/08/25	Medical device firm LeMaitre Q2 sales beat expectations	RE
28/02/25	Oppenheimer Downgrades LeMaitre Vascular to Market Perform From Overweight, Price Target is $45	MT
13/02/25	Wells Fargo Initiates LeMaitre Vascular at Equalweight With $95 Price Target	MT
15/10/24	Cantor Fitzgerald Initiates LeMaitre Vascular at Neutral With $96 Price Target	MT
31/05/24	Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target	MT
03/05/24	Barrington Boosts Price Target on LeMaitre Vascular to $79 From $69, Keeps Outperform Rating	MT
26/04/24	Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59	MT
28/02/24	Barrington Raises Price Target on LeMaitre Vascular to $69 From $66, Keeps Outperform Rating	MT
23/10/23	JMP Securities Initiates LeMaitre Vascular With Market Outperform Rating, Price Target is $60	MT
06/09/23	Oppenheimer Initiates Coverage on LeMaitre Vascular With Outperform Rating, $70 Price Target	MT
03/08/23	Jefferies Downgrades LeMaitre Vascular to Hold From Buy, Adjusts Price Target to $67 From $63	MT
02/08/23	Barrington Raises Price Target on LeMaitre Vascular to $66 From $62, Maintains Outperform Rating	MT
03/05/23	Stifel Raises LeMaitre Vascular's Price Target to $60 From $48, Hold Rating Kept	MT
03/05/23	Jefferies Raises LeMaitre Vascular's Price Target to $63 From $57, Maintains Buy Rating	MT
03/05/23	Roth MKM Raises LeMaitre Vascular's Price Target to $54 From $48, Neutral Rating Kept	MT
03/05/23	Barrington Research Upgrades LeMaitre Vascular to Outperform From Market Perform	MT
28/10/22	Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform	MT
29/04/22	Barrington Lowers LeMaitre Vascular's Price Target to $50 From $54, Maintains Outperform Rating	MT
25/02/22	Barrington Research Trims LeMaitre Vascular's Price Target to $54 From $62, Maintains Outperform Rating	MT
29/10/21	Barrington Adjusts Price Target on LeMaitre Vascular to $62 From $64, Maintains Outperform Rating	MT

More recommendations

Other Advanced Medical Equipment & Technology

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	LEMAITRE VASCULAR, INC.					+35.51%
	THERMO FISHER SCIENTIFIC, INC.					-0.3%
	DANAHER CORPORATION					+9.65%
	INTUITIVE SURGICAL, INC.					+21.53%
	BOSTON SCIENTIFIC CORPORATION					+42.71%
	EDWARDS LIFESCIENCES CORPORATION					+18.57%
	SIEMENS HEALTHINEERS AG					+20.24%
	AGILENT TECHNOLOGIES, INC.					+4.42%
	VEEVA SYSTEMS INC.					+8.77%
	WATERS CORPORATION					+5.57%
	Average					+16.67%
	Weighted average by Cap.					+11.84%